Novavax vaccine will likely find its place as vaccination rates decline, expert

Five on 2

MORAINE, Ohio (WDTN) — As vaccination rates begin to slow, U.S. biotech company Novavax announced that its two dose COVID vaccination is 90.4% effective.

Dr. Roberto Colon, chief medical officer at Miami Valley Hospital, said the big difference between the Novavax vaccine and the others, is that it has pieces of spike protein that teach your body to create antibodies.

“I think right now, we’ve probably have sufficient amount of vaccines. And if you look at Novavax they’re probably not planning on moving on a [Emergency Use Authorization] until a little bit later on this year,” said Colon.

The company hopes the fourth vaccine will become a booster shot if those are needed as people approach the one year mark. Colon said renewed interest in vaccination once the 2021-22 school year begins could see it used as well.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

More As Seen on 2 NEWS

Trending Stories

Don't Miss

More stories not to miss...

Latest News Videos

Miami Valley health leaders believe mask mandate isn't necessary as cases rise

Dayton Police Chief Richard Biehl retires after 13 years of service

The Neon announces fundraising campaign to help update technology

No more border fed phone seizures

Rep. Phil Plummer announces bid for Ohio House Speaker

What can Montgomery County renters expect once the US eviction moratorium ends?

More News